Although those with a larger range of invasion and negative PRL immunohistochemistry were still more likely to experience recurrence in the external test set, there was no statistical significance between the recurrence group and the non-recurrence group in terms of tumor invasion site (P = 0.113) and immunohistochemical PRL positivity (P = 0.162). The gene discussed is PRL; the disease is neoplasm.